The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $95.00

Today's change-0.51 -0.53%
Updated January 23 4:01 PM EST. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $95.00

Today's change-0.51 -0.53%
Updated January 23 4:01 PM EST. Delayed by at least 15 minutes.

Edwards Lifesciences Corp down (U.S.)$0.51

Edwards Lifesciences Corp closed lower Monday, dropping (U.S.)$0.51 or 0.53% to (U.S.)$95.00. Shares have lost 2.19% for the last five days, but have gained 20.50% over the last 52 weeks. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $95.50
  • Previous close(U.S.) $95.51
  • High(U.S.) $95.60
  • Low(U.S.) $94.27
  • Bid / Ask(U.S.) $89.57 / (U.S.) $95.45
  • YTD % change+1.39%
  • Volume1,142,974
  • Average volume (10-day)1,760,269
  • Average volume (1-month)2,132,067
  • Average volume (3-month)2,171,303
  • 52-week range(U.S.) $75.24 to (U.S.) $121.75
  • Beta0.54
  • Trailing P/E37.57×
  • P/E 1 year forward33.36×
  • Forward PEG1.92×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.53
Updated January 23 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.44%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue739759697671
Total other revenue--------
Total revenue739759697671
Gross profit538557517495
Total cost of revenue201203180176
Total operating expense554590514504
Selling / general / administrative230229213222
Research & development11311310298
Depreciation / amortization--------
Interest expense (income), net operating------5
Unusual expense (income)744123
Other operating expenses, total3951
Operating income185169183167
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax185169183167
Income after tax141127143141
Income tax, total44424026
Net income141127143141
Total adjustments to net income--------
Net income before extra. items141127143141
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items141127143141
Inc. avail. to common incl. extra. items141127143141
Diluted net income141127143141
Dilution adjustment0--01
Diluted weighted average shares218217218221
Diluted EPS excluding extraordinary itemsvalue per share0.650.580.660.64
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.670.730.700.65